Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05766891 · ClinicalTrials.gov registry record · Phase 2

Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery

A Phase 2 study of Breast Cancer, sponsored by M.D. Anderson Cancer Center.

Recruiting
Registry status
Phase 2
Development phase
225
Enrollment target
1
Study location

NCT05766891: Recruiting Phase 2 study of Breast Cancer, sponsored by M.D. Anderson Cancer Center.

NCT05766891 is a Phase 2 study of Breast Cancer that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 225 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05766891, a Phase 2 study of Breast Cancer, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.

RECRUITING
Registry status
Phase 2
Development phase
225 participants
Enrollment target
1
Study location

Study Summary

To hypnosedation alone given before and during surgery on reducing opioid use after surgery compared to standard general anesthesia given alone or with hypnosedation.

Conditions Studied

Interventions

  • BEHAVIORAL Group 1
  • BEHAVIORAL Group 2
  • BEHAVIORAL Group 3

Study Locations (1)

Texas

  • M D Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 225 participants
Start Date 2023-10-12
Est. Completion 2028-12-31
Phase Phase 2

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT05766891

The ClinicalTrials.gov registry entry for NCT05766891 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 225 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (92% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 3 interventions - of which Group 1 is the first listed.

NCT05766891 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05766891 about?

NCT05766891 is a clinical study titled "Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery". To hypnosedation alone given before and during surgery on reducing opioid use after surgery compared to standard general anesthesia given alone or with hypnosedation.

What is the current status of trial NCT05766891?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 225 participants. The study started on 2023-10-12. Estimated completion is 2028-12-31.

What conditions does trial NCT05766891 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT05766891?

The interventions under investigation include: Group 1 (BEHAVIORAL), Group 2 (BEHAVIORAL), Group 3 (BEHAVIORAL).

Who is sponsoring clinical trial NCT05766891?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05766891 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.